Market cap
₹1 Cr
Revenue (TTM)
₹16 Cr
P/E Ratio
--
P/B Ratio
-0
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 48.48 | 297.93 | -3.00 |
| EBIT | 10.04 | -173.10 | -335.68 | 15.84 | -0.83 |
| Net Profit | 0.27 | -37.76 | -35.27 | 6.31 | -236.80 |
| EPS | 0.27 | -37.76 | -35.27 | 6.31 | -236.80 |
| Book Value | -- | -- | -19.57 | -34.96 | -300.88 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-12 | Mar-11 |
| EBIT-Margin
| -5,328.48 | -4,234.29 | -- | -26.41 | -2.83 |
| Net Margin
| -3,838.53 | -2,937.69 | -- | -115.14 | -122.35 |
| Return on equity
| 0.00 | -22.72 | -- | 0.00 | 0.00 |
| Return on Capital
| -14.14 | -44.50 | -- | -20.34 | -0.94 |
| Return on Assets
| -55.73 | -69.73 | -84.89 | -69.05 | -45.33 |
| Debt to Equity (x)
| -- | -- | 0.00 | -1.16 | -1.23 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
--
|
-20.34
|
-0.94
|
-21.14
|
-176.22
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
9.23
|
--
|
--
|
--
|
--
|
ROA
-84.89
Lower than Peers by 92.01
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
-84.89
|
-69.05
|
-45.33
|
-52.80
|
-176.47
|
|
Peer Median
|
7.12
|
--
|
--
|
--
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
--
|
-26.41
|
-2.83
|
-15,956.19
|
-5,175.76
|
|
Peer Median
|
5.25
|
--
|
--
|
--
|
--
|
Net Margin
--
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
--
|
-115.14
|
-122.35
|
-11,278.09
|
-3,163.24
|
|
Peer Median
|
4.35
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
--
|
-102.73
|
-103.57
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
--
|
48.48
|
--
|
-89.37
|
-99.01
|
|
Peer Median
|
7.89
|
--
|
--
|
--
|
--
|
EBIT Growth
-335.68
Lower than Peers by 340.82
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
-335.68
|
-1,284.47
|
92.92
|
67.22
|
-401.92
|
|
Peer Median
|
5.14
|
--
|
--
|
--
|
--
|
Net Profit Growth
-35.27
Lower than Peers by 49.21
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
-35.27
|
-39.66
|
15.93
|
76.31
|
-2,547.98
|
|
Peer Median
|
13.94
|
--
|
--
|
--
|
--
|
EPS Growth
-35.27
--
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
-35.27
|
-39.66
|
15.93
|
76.31
|
-2,547.98
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
--
|
-19.57
|
-16.30
|
-24.04
|
-6,888.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
--
|
-1.16
|
-1.23
|
-1.26
|
-1.29
|
|
Peer Median
|
0.15
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-1.16
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
-1.16
|
-1.16
|
-1.23
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.02
Lower than Peers by 1.27
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
0.02
|
0.03
|
0.07
|
0.66
|
0.46
|
|
Peer Median
|
1.29
|
--
|
--
|
--
|
--
|
Quick Ratio
0.01
Lower than Peers by 0.88
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
0.01
|
0.02
|
0.04
|
0.61
|
0.41
|
|
Peer Median
|
0.88
|
--
|
--
|
--
|
--
|
Interest Coverage
-0.27
Lower than Peers by 5.44
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
-0.27
|
-0.27
|
-0.02
|
-0.36
|
-14.30
|
|
Peer Median
|
5.17
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
--
|
0.98
|
16.06
|
96.14
|
10.22
|
|
Peer Median
|
17.17
|
--
|
--
|
--
|
--
|
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
--
|
0.59
|
0.37
|
0.00
|
0.01
|
|
Peer Median
|
1.42
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
--
|
21.53
|
29.75
|
350.91
|
4,544.30
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
--
|
56.26
|
66.50
|
7,634.12
|
2,963.88
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
--
|
106.76
|
290.69
|
--
|
136.34
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
--
|
-28.96
|
-194.44
|
7,985.02
|
7,371.84
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
185.27
|
--
|
--
|
--
|
--
|
Price / Book Value
-0.01
Lower than Peers by 5.82
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
-0.01
|
-0.02
|
-0.03
|
-0.04
|
-0.04
|
|
Peer Median
|
5.82
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.18
|
--
|
--
|
--
|
--
|
EV/EBITDA
-64.09
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
-64.09
|
-74.16
|
58.52
|
-54.48
|
-9.73
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
1
Lower than Peers by 357
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-12
|
Mar-11
|
Mar-10
|
Mar-09
|
|---|---|---|---|---|---|
|
Polar Pharma India
|
1
|
3
|
3
|
3
|
3
|
|
Peer Median
|
358
|
--
|
--
|
--
|
--
|